Primary care providers need more education when it comes to PrEP, not only for them, but also for patients, who often think they need to see a specialist just to take this preventative medicine.
Steven Deeks, M.D., talks about the medical community's hopes, inspirations, and unanswered questions regarding research for an HIV cure.
Does Descovy Really Work Better Than Truvada for PrEP? One Researcher Raises Questions About the DISCOVER Trial Results
Newly presented data from IAS 2019 spark discussion about study populations, study endpoints, and potential weight gain.
On-demand pre-exposure prophylaxis may be best for people with episodic risk who cannot or would prefer not to take the pill every day.
"Being transgender is not necessarily an HIV risk factor," Joshua D. Safer, M.D., says.
A team led by Shannon Weber, M.S.W., has developed PleasePrEPMe, an online PrEP provider search and chat service.
These social justice-minded researchers at the University of North Carolina-Chapel Hill form a close-knit group that strives to counter stigma and discrimination against people of a gender minority, particularly people of color.
Distal sensory polyneuropathy affects approximately 50% of persons living with HIV. We spoke with neuroscience mentor and mentee to discuss how to reduce the risk of neuropathy and what treatments are available.
We spoke with a mentor/mentee pair, an infectious diseases expert and a second-year medical student, about a research project that focuses on HIV drug resistance in trans women and MSM.
Richard Jefferys, an expert in HIV cure research, spoke to TheBodyPro about this new case of HIV remission -- and the danger in rushing to publish these stories, especially for people who live with stigma.